ADAM17 and hereditary hemorrhagic telangiectasia: Our findings suggest the effects of genetic modifier variants are complex, but given the functional data from animal and in vitro models for the involvement of ADAM17 and PTPN14 in HHT biology (Benzinou et al., 2012; Kawasaki et al., 2014), it is of interest to revisit these in larger cohorts.